First Volumetric OCT Device Cleared in the US for Endoscopic, Esophageal Imaging
By MedImaging International staff writers Posted on 06 May 2013 |
Image: The NvisionVLE imaging system (Photo courtesy of NinePoint Medical).
For the first time, an optical coherence tomography (OCT) imaging system will enable both physicians and pathologists to visualize real-time, high-resolution, volumetric images of organs and tissues up to 3-mm deep, at better than 10-micrometer resolution.
NinePoint Medical, Inc. (Cambridge, MA, USA), a developer of medical devices for in vivo imaging, reported that it has received an additional 510(k) clearance from the US Food and Drug Administration (FDA) for its NvisionVLE imaging system, expanding the system’s indication to include imaging of esophageal tissue microstructure. In January 2012, the company reported 510(k) clearance from the FDA to market its NvisionVLE imaging system for use as an imaging application in the assessment of human tissue microstructure by providing two-dimensional (2D), cross-sectional, real-time depth visualization.
“The NvisionVLE imaging system is the first and only volumetric, optical coherence tomography device cleared by the FDA for endoscopic imaging, and now imaging of esophageal tissue microstructure,” said Charles Carignan, MD, president and chief executive officer of NinePoint Medical. “Expanded FDA 510(k) clearance for imaging of the esophagus represents an important milestone as we progress toward commercializing the NvisionVLE imaging system this year. We believe that the NvisionVLE imaging system will allow physicians to see more esophageal tissue for biopsy and treatment procedures, providing them with valuable imaging information.”
NinePoint is preparing for a commercial launch of the NvisionVLE imaging system in the United States in May 2013. The system is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization.
Related Links:
NinePoint Medical
NinePoint Medical, Inc. (Cambridge, MA, USA), a developer of medical devices for in vivo imaging, reported that it has received an additional 510(k) clearance from the US Food and Drug Administration (FDA) for its NvisionVLE imaging system, expanding the system’s indication to include imaging of esophageal tissue microstructure. In January 2012, the company reported 510(k) clearance from the FDA to market its NvisionVLE imaging system for use as an imaging application in the assessment of human tissue microstructure by providing two-dimensional (2D), cross-sectional, real-time depth visualization.
“The NvisionVLE imaging system is the first and only volumetric, optical coherence tomography device cleared by the FDA for endoscopic imaging, and now imaging of esophageal tissue microstructure,” said Charles Carignan, MD, president and chief executive officer of NinePoint Medical. “Expanded FDA 510(k) clearance for imaging of the esophagus represents an important milestone as we progress toward commercializing the NvisionVLE imaging system this year. We believe that the NvisionVLE imaging system will allow physicians to see more esophageal tissue for biopsy and treatment procedures, providing them with valuable imaging information.”
NinePoint is preparing for a commercial launch of the NvisionVLE imaging system in the United States in May 2013. The system is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization.
Related Links:
NinePoint Medical
Latest General/Advanced Imaging News
- Bone Density Test Uses Existing CT Images to Predict Fractures
- AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans
- Radiation Therapy Computed Tomography Solution Boosts Imaging Accuracy
- PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients
- Artificial Intelligence Evaluates Cardiovascular Risk from CT Scans
- New AI Method Captures Uncertainty in Medical Images
- CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
- Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
- CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
- Minimally Invasive Procedure Could Help Patients Avoid Thyroid Surgery
- Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery
- AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning
- Imaging Technology Provides Ground-Breaking New Approach for Diagnosing and Treating Bowel Cancer
- CT Coronary Calcium Scoring Predicts Heart Attacks and Strokes
- AI Model Detects 90% of Lymphatic Cancer Cases from PET and CT Images
- Breakthrough Technology Revolutionizes Breast Imaging